Leadership

Halo Leadership Team

aaron davenport

Aaron Davenport

Chairman

Mr. Davenport is a Managing Director at SK Capital and plays a leading role in all aspects of the firm’s investment strategy.  He focuses on both the healthcare and specialty chemicals industries and currently serves as Chairman of Halo Pharmaceutical, AEB Group, Noramco, Inc. and Tasmanian Alkaloids and as a member of the Board of Directors of Archroma.  He previously served on the Board of Directors of IBA Molecular. He joined the firm in 2010....

Read More
Lee Karras

Lee Karras

CEO

Lee Karras is an established pharmaceutical business executive with over twenty five years of healthcare industry related experience. Prior to joining Halo, Lee held executive leadership roles in several businesses. Most recently he was President of IBA Molecular North America, a global leader in the manufacture and distribution of generic radiopharmaceuticals. Prior to IBA Molecular, Lee spent four years with AAIPharma Services where he was hired to reestablish the CDMO from bankruptcy and did so...

Read More
Barry Lederman

Barry Lederman

CFO

Barry Lederman has extensive financial and international pharmaceutical experience, having led teams of several public and private companies with global operations. Prior to joining Halo, he served as the Vice President and CFO for Eisai Inc. with operations in the Americas Region, the CFO at Wedgewood Pharmacy, Nycomed US Inc., and Qualitrol Company LLC (a subsidiary of Danaher Corporation). Mr. Lederman also spent 10 years with Roche in positions of increasing responsibility within Finance, culminating...

Read More
Maryse Laliberté

Maryse Laliberté

VP/General Manager Mirabel

Maryse brings overs 23 years’ experience in the development and the manufacture of pharmaceutical and biological products which included leadership roles in the characterization of proteins, technology transfer of cream, ointment, liquid and solid dosage form and, in-line support of external partner manufacturing of consumer care and drug products. Prior to joining Halo, Maryse has worked in numerous roles in the pharmaceutical industry. Her most recent assignment was in the Global Technology Organization of Merck...

Read More
James Cherry

James Cherry

VP/General Manager Whippany

Jim brings over 25 years’ experience in the technical transfer and commercial manufacture of pharmaceutical products.  This experience includes leadership roles in manufacturing, validation and technology transfer of cream, ointment, liquid, gel and solid dosage forms. Prior to joining Halo, Jim has worked in numerous roles in the pharmaceutical industry. His most recent assignment was at Fougera Pharmaceuticals where Jim held roles of Executive Director of Manufacturing Technology and Vice President of Manufacturing.  He was...

Read More
Anthony Qu

Anthony Qu, PhD.

VP Pharmaceutical Development

Dr. Qu brings over 27 years of Research and Development and Project Management experience to Halo. Prior to joining Halo, Dr. Qu was the Director of Product Development at Patheon. While at Patheon, Dr. Qu lead and directed a group of 100+ scientific staff developing projects (NDA, 505B2, ANDA) for various clients. Dr. Qu oversaw the Formulation and Process Development, Analytical Development, Project Management and Clinical Packaging Departments. Successfully transferred more than 100+ projects from...

Read More